Editor's key points † Intracranial haematomas are a rare but serious complication of craniotomy surgery. † The authors analysed a large neurosurgical database to assess risk factors for haematomas requiring surgery. † Hypertension during craniotomy, after craniotomy, or both were significant factors. † Administration of flurbiprofen during, but not after, craniotomy was associated with haematoma development.
antiplatelet effects and this is the main reason for the reluctance by some to routinely use them. 6 7 There are numerous studies in major surgery showing that patients receiving NSAIDs, especially chronic use, have a higher risk of bleeding than patients receiving placebo. 3 8 Conversely, there are studies showing that acute perioperative use does not significantly increase bleeding. 9 11 This issue has not been well investigated in the neurosurgical literature. Colloids are commonly used for acute restoration and stabilization of systemic intravascular volume and improved tissue perfusion during surgery. 12 However, the infusion of hydroxyethyl starch (HES) solution is associated with haemostatic alterations by inhibiting platelet function, reducing von Willebrand factor, and fibrin polymerization. 13 Whether the intraoperative infusion of HES is associated with post-craniotomy intracranial haematoma is not known.
In the current study, we tested the hypothesis that postcraniotomy intracranial haematoma requiring surgery is associated with perioperative hypertension, the use of flurbiprofen, and the infusion of HES. We conducted a case -control study, examining all patients who suffered post-craniotomy intracranial haematoma during a 6-yr period at Beijing Tiantan Hospital and comparing them with a matched control group who did not have an intracranial haematoma. Beijing Tiantan Hospital is a single medical centre affiliated to Capital Medical University and one of Asia's busiest neurosurgical hospitals performing 8000 neurosurgical procedures a year.
Methods
The study was approved by the Institutional Review Board at Beijing Tiantan Hospital. Because patients were not subjected to investigational actions and only de-identified retrospective data would be used, no written informed consent was required. For similar reasons, this study was not registered with a clinical trials registry. We performed a retrospective case-control study. All patients who underwent elective craniotomy at Beijing Tiantan Hospital from January 2006 to December 2011 were screened (M.J.) in the hospital's database system for a diagnosis of 'haematoma' and 'post-craniotomy intracranial haematoma' which was confirmed by computed tomography scan and required surgery. Then another anaesthesiologist (X.L.) searched the anaesthetic record system for all the patients admitted to the operating room with the diagnosis of postoperative intracerebral haematoma. By searching two separate databases, we are confident that all the patients were included. Thereafter, we excluded patients for whom complete medical records could not be obtained.
Perioperative patient data were collected from medical records. All the electronic medical records were reviewed by two reviewers both of whom were anaesthesiologists (M.J., X.L.) to ensure the validity of the data. These consisted of patients' age, gender, ASA grade, past medical history, preoperative laboratory data, location and histology of the brain tumour, date of first operation, operative details such as the type of anaesthetic administered, occurrence of preoperative, intraoperative and postoperative hypertension, the use of flurbiprofen, estimated surgical blood loss, intraoperative crystalloid and colloid fluids given and operative duration, date of second operation, and the site and volume of the haematoma. Outcomes of patients were assessed according to the length of hospital stay and Karnofsky performance status (KPS) 14 score at discharge. Preoperative hypertension was defined as a history of hypertension recorded in the medical record. Intraoperative and postoperative hypertension were defined as the maximum blood pressure both absolute, .160/90 mm Hg or mean (MBP) .110 mm Hg, and relative to the baseline (.20% increase from the baseline). All the blood pressures during the surgery were measured through an arterial line and recorded every 5 min. We also compared the use of vasodilator drugs between the two groups. The baseline blood pressure was defined as the blood pressure measured at preoperative evaluation the day before surgery.
Flurbiprofen is the only injected i.v. NSAIDs in our hospital. The use of flurbiprofen included bolus i.v. administration during surgery and continuous i.v. administration after surgery. The dose of flurbiprofen during surgery was 50 mg; the dose of flurbiprofen after surgery was 1.5 mg kg 21 day 21 .
For every patient with a post-craniotomy haematoma, one control patient was matched by age (5 yr) and date of surgery (1 week), the same pathologic diagnosis (meningioma, glioma, aneurysm, pituitary tumour, metastatic neoplasm, or other), tumour location, and attending surgeon.
Statistical analysis
Categorical variables are reported as frequency and per cent. The rates of occurrence of perioperative hypertension and the use of flurbiprofen were compared using the Pearson chisquare test and are presented as odds ratios (ORs) for postcraniotomy intracranial haematoma and 95% confidence intervals (CIs). Normally distributed continuous variables are reported as mean (SD) and compared using the two-sample t-test. Continuous variables, not normally distributed, are reported as median with the interquartile range representing the difference between the 25th and 75th percentiles and compared using the Mann-Whitney test.
Conditional logistic regression was used to examine the association between haematoma and the occurrence of perioperative hypertension and the use of flurbiprofen and HES. A significance level of P≤0.05 was used for each hypothesis. The statistical analysis was performed with the SPSS software version 13.0.
Results
There were 42 359 patients who underwent craniotomy at Beijing Tiantan hospital from January 2006 to December 2011. Of these patients, there were 202 (0.48%) postcraniotomy haematoma surgeries according to our anaesthestic record system. After we reviewed these cases one by one, it turned out that 13 patients underwent a third surgery, mainly decompressive craniectomy for brain oedema, after the second surgery. Therefore, there were 189 patients who suffered a post-craniotomy haematoma in our study. Five patients were excluded for incomplete medical records, so the total number of patients that could be analysed for this study was 184 with post-craniotomy intracranial haematoma and a matched control group of 184 patients. These data were also confirmed by hospital medical records and discharge diagnosis.
The clinical characteristics of the post-craniotomy haematoma and the control groups are shown in Table 1 . There were no significant differences in biological data. There were .000], and mortality was higher (12% vs 0, P¼0.001). Table 2 shows the incidence of perioperative hypertension in the two groups. Although there was a significant difference in absolute blood pressures, the percentage increase from the baseline showed no significant difference between the two groups. Table 3 shows the use of flurbiprofen between these two groups. Patients with post-craniotomy intracranial haematoma were more likely to have received flurbiprofen during surgery (OR¼2.14, 95% CI¼1.23-3.58, P¼0.003). The use of flurbiprofen after surgery was not significantly different between the groups. There was no difference in platelet count or blood loss within the haematoma group in those who received the drug vs those who did not receive a drug bolus.
In a multivariable conditional logistic regression model which is shown in Table 4 , post-craniotomy intracranial haematoma was associated with an intraoperative maximum systolic blood pressure of .160 mm Hg (OR¼2.618, 95% CI¼2.084-2.723, P¼0.007), an intraoperative maximum mean blood pressure of .110 mm Hg (OR¼2.600, 95% CI¼2.312-3.098, P¼0.037), a postoperative maximum systolic blood pressure of .160 mm Hg (OR¼2.060, 95% CI¼ 1.763-2.642, P¼0.022), a postoperative maximum mean blood pressure of .110 mm Hg (OR¼3.600, 95% CI¼3.226-4.057, P¼0.001), and the use of flurbiprofen during the surgery (OR¼2.256, 95% CI¼2.004-2.598, P¼0.005). Post-craniotomy intracranial haematoma was not associated with intraoperative maximum systolic blood pressure increase 20% than baseline (P¼0.361), intraoperative maximum mean blood pressure increase 20% than baseline (P¼0.712), postoperative maximum systolic blood pressure increase 20% than baseline (P¼0.062), postoperative maximum mean blood pressure increase 20% than baseline (P¼0.543), the use of flurbiprofen after surgery (P¼0.078), the intraoperative infusion of HES (P¼0.55), operative duration (P¼0.233), or blood loss during the surgery (P¼0.308). Figure 1 shows the temporal distribution of postoperative intracranial bleeding episodes for all of the 184 haematoma patients. Approximately 60% of the post-craniotomy intracranial haematomas occurred ,24 h after surgery. Among the patients who received flurbiprofen during surgery, the median time from the end of surgery to haematoma was 12 (4-24) h, and for those who did not receive flurbiprofen during surgery, the median time was 24 (6-96) h (P¼0.000). Among the post-craniotomy intracranial haematoma patients, the haematoma volume was not significantly different between patients who received flurbiprofen and who did not [20 (15 -40) ml vs 20 (10 -40) ml, P¼0.800].
Discussion
Using the large neurosurgical database of 42 359 patients at Beijing Tiantan hospital, we found the incidence of postcraniotomy intracranial haematoma requiring surgery to be 0.48% (95% CI¼0.41-0.55). The main finding of our study is that both perioperative hypertension, systolic .160 mm Hg, mean .110 mm Hg, or both, and acute use of the NSAID flurbiprofen during neurosurgery were significant risk factors for symptomatic haematoma formation requring surgery.
Hypertension may increase the incidence of postcraniotomy intracranial haematoma by multiple possible mechanisms. If blood pressure exceeds the upper extent of cerebral autoregulation, this will result in increases in cerebral blood flow, which in turn can break down the blood-brain barrier with resultant transudation of intravascular fluid 15 and haemorrhage. 16 17 It is also possible that the area of brain immediately adjacent to the tumour bed may have lost its autoregulatory ability so that hypertension results in breakthrough bleeding as has been described for arteriovenous malformations. 18 The high representation of meningioma patients in our series, a frequently vascular tumour, is consistent with this suggestion. Early in the perioperative period hypertension by suddenly increasing pulse pressure and flow could dislodge immature thrombus. 19 Basali and colleagues found that a blood pressure of .160/90 mm Hg in the perioperative period significantly predisposed to post-craniotomy intracranial haematoma, 4 which is similar to our result. Unlike Basali,
we also assessed percentage change in blood pressure from baselines as a risk factor. We did not find a difference in percentage blood pressure change between the haematoma group and the control group. This implies an absolute threshold for haemorrhage rather than a relative one and is perhaps consistent with evidence from patients with intracranial haemorrhage where lowering blood pressure ,140/90 mm Hg, rather than a percentage, is recommended. 20 We chose a blood pressure threshold of 160/90 so that our results would be comparable with those of previous studies in the literature but is also consistent with previously accepted criteria. 21 It should be remembered that hypertension could both be the cause and the consequence of an intracranial haematoma. An acute increase in intracranial pressure results in sympathetic discharge provoking an increase in blood pressure in an attempt to restore or maintain cerebral perfusion pressure. 22 Neither our study nor the previous ones are able to determine the sequence. All that can be reported is the association and the assumption that the increase in blood pressure is the cause rather than the consequence. Post-craniotomy intracranial haematoma is most likely because of the surgical technique. However, haemostatic factors including the number and function of platelets, normal blood coagulation factors, and adaqute fibrinolysis may contribute as well. In our study, the haematoma group lost more blood [500 (300 -1000) ml vs 400 (300-800 ml)] than the control group during surgery. The number of platelets was also less than that in the control group; some of the patients may have been thrombocytopaenic. This might affect the haemostasic status. However, the number of platelets in the haematoma group was still in the normal range and it is platelet function rather than number that would be affected by flurbiprofen. Platelet function is not routinely measured in clinical practice. It seems to us that these small differences in blood loss and platelet number are unlikely to account for the difference in haematoma incidence.
NSAIDs are widely used as perioperative analgesics to reduce the need for opioids and their associated adverse effects after many surgical procedures. 23 They have the disadvantage that they can interfere with normal haemostasis by inhibiting arachidonic acid-derived prostaglandins generated via the cyclooxygenase (COX) pathway. 6 Flurbiprofen is an NSAID widely used in China for postoperative pain and also used in other countries for acute and chronic pain management. 24 -26 There are few studies specifically concerning the effects on coagulation but as it has both COX1 and COX2 effects, it is reasonable to assume that its coagulation effects are similar to those of other drugs in the same class. There was no association between hypertension and flurbiprofen use but we cannot exclude the possibility that the analgesic was given to control pain which was assumed to be causing hypertension, that is, the hypertension rather than the NSAID was responsible for the bleeding. The use of NSAIDs after craniotomy is controversial. 27 While NSAIDs are anecdotally used in Asia and Europe, detailed reporting is scant 28 but some studies have shown a benefit. 9 -11 29 A recurrent concern is postoperative haematoma. 30 Unfortunately, reports do not clearly differentiate between patients chronically taking NSAIDs from only acute perioperative administration, such as used at our institution. For example, Palmer and colleagues reported that an increase in post-craniotomy intracranial haematoma was associated with the chronic use of aspirin or other NASIDs. 3 In our study, it was the acute intraoperative bolus use of flurbiprofen that was the risk factor for post-craniotomy intracranial haematoma (OR¼2.14, 95% CI¼1.23 -3.58, P¼0.003) and not postoperative use. In our study, as in others in the literature, most postoperative haematomas occur within the first 24 h, with the majority in the first 6 h. 31 The bolus dose of flurbiprofen during surgery was 50 mg, resulting in a rapid increase in concentration. The dose of flurbiprofen after surgery was 1.5 mg kg 21 day 21 , and therefore, a slower increase in concentration and possibly a lower plasma level. Furthermore, after operation there is much better or more secure clot stabilization. These factors probably collectively explain the improved safety with postoperative use. We therefore recommend that bolus use of flurbiprofen, and probably other similar agents, be avoided during surgery and 24 h thereafter. HES can inhibit platelet reactivity and cause clinical bleeding problems perioperatively. 32 33 The 'third-generation' HES 130/ 0.4 is considered to be an improved and safer solution because of its lower molecular weight (130 kDa) and lower degree of substitution (0.4), which leads to lesser interference with coagulation. 34 However, HES 130/0.4 is still associated with hypocoagulation through a weaker and smaller clot with a less stable fibrin network and less firm aggregation of platelets. 35 Our study shows that the intraoperative infusion of HES 130/0.4 is not associated with post-craniotomy intracranial haematoma (P¼0.461). However, there remain concerns about the safety of HES 130/0.4 in surgical, emergency, or intensive care patients because of the inadequacy of the clinical trials. 36 The incidence of post-craniotomy intracranial haematoma in our series, 0.48%, is less than many previously reported. 1 5 Previous studies found rates between 0.8 and 7%. Many reasons may explain the differences including the fact that many of the previous studies had relatively small sample sizes and represented clinical practice between 1976 and 1992. Basali and colleagues, which is one of the largest reports, spans 17 yr, 1976 -1992. 5 Our study covers just 6 yr.
Studies differ in the exact definition of post-craniotomy intracranial haematoma and the length of the postoperative period included. In our study, the inclusion criteria were quite tight, we chose only patients who suffered a post-craniotomy intracranial haematoma and were treated surgically. This provided a very concrete, easily identifiable outcome. There were likely additional patients with haematomas but presumably not of sufficient clinical consequences to merit surgery. Such an approach is consistent with previous studies but does mean that not all the post-craniotomy intracranial haematomas were included. 4 Other considerations include the fact that patient characteristics differ across studies in terms of age, gender, and risk factors such as diabetes and chronic hypertension. We also used a case -control ratio of 1:1, which differs from others who used 1:3. The main advantage, especially when a small number of patients is anticipated, is an increase in power. Given our large patient population, we anticipated a large case volume. Of importance is that even with a 1:1 ratio, we found highly statistically significant differences between haematoma patients and controls.
In conclusion, our retrospective case -control study of postcraniotomy intracranial haematoma obtained from 42 359 patients more than 6 yr is the largest reported. We found an incidence of post-craniotomy intracranial haematoma at Beijing Tiantan Hospital requring surgery to be 0.48%. The development of post-craniotomy intracranial haematoma requring surgery was associated with intraoperative and postoperative hypertension defined as a blood pressure of .160/90 mm Hg, a mean blood pressure of 110 mm Hg or both, and the use of the intraoperative NSAID flurbiprofen but not after operation.
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